Nasheeta Peer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nasheeta Peer has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
- Andre Pascal Kengne
Non-Communicable Diseases Research Unit, South African Medical Research Council, Tygerberg 7505, South Africa
32 shared publications - Carl Lombard
Affiliations Biostatistics Research Unit, South African Medical Research Council, Cape Town, South Africa, Division of Epidemiology and Biostatistics, Stellenbosch University, Cape Town, South Africa
14 shared publications Krisela Steyn
Affiliation Department of Medicine, Chronic Disease Initiative for Africa, UCT, Cape Town, South Africa
12 shared publications- Naomi Sharlene Levitt
Division of Endocrinology, Department of Medicine, University of Cape Town, Cape Town, South Africa
10 shared publications - Jillian Hill
Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa
7 shared publications - Kim Anh Nguyen
Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town 7925, South Africa
7 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
The relationship between cardiovascular health and common mental disorders among adults aged ≤ 50 years: a systematic review of observational studies
Background: Depression and anxiety are common among younger adults and contribute to adverse physical and social outcomes. Evidence suggests a potential bidirectional relationship between common mental disorders (CMDs) and cardiovascular health (CVH). However, this has not been directly established. This review examined the relationship between CVH and CMDs in individuals aged 15–50 years. Methods: MEDLINE (PubMed), APA PsycINFO, Web of Science, and CINAHL (EBSCO) were searched from inception to 4 November 2024. Observational studies reporting depressive or anxiety symptoms and CVH defined by Life’s Simple 7, Life’s Essential 8, or adapted composite indices were eligible. Study quality was appraised using the Newcastle-Ottawa Scale and a narrative synthesis was conducted. Findings: Of 25 full-text articles assessed, 11 studies ( n = 731,650; mean age 22–48 years) met the inclusion criteria. Nine were conducted in the United States, one in China, and one in Puerto Rico. Seven cross-sectional studies reported an inverse association between CVH and CMDs, with higher CVH associated with lower odds or prevalence of depressive and anxiety symptoms. Four studies, including one cohort, found that CMDs were associated with lower CVH, reflected by higher odds of suboptimal CVH, lower prevalence of ideal CVH, and reduced CVH scores. Conclusions: Findings suggest a potential bidirectional relationship between CVH and CMDs among adults, though this is inferred from separate analyses rather than directly established using the same studies. Integrated strategies promoting physical activity, a healthy diet, and stress management, alongside primary care initiatives incorporating behavioural support and screening for cardiovascular and mental health risks, may benefit both conditions. Interpretation is limited by the predominance of cross-sectional studies and heterogeneity in study designs, with most studies conducted in high-income settings. Future research should prioritise longitudinal designs and apply diverse analytical methods to better clarify directionality. Registration: PROSPERO (CRD42024621494).
- 16 June 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Open AccessThe relationship between cardiovascular health and common mental disorders among adults aged ≤ 50 years: a systematic review of observational studies
Background: Depression and anxiety are common among younger adults and contribute to adverse physical and social outcomes. Evidence suggests a potential bidirectional relationship between common mental disorders (CMDs) and cardiovascular health (CVH). However, this has not been directly established. This review examined the relationship between CVH and CMDs in individuals aged 15–50 years. Methods: MEDLINE (PubMed), APA PsycINFO, Web of Science, and CINAHL (EBSCO) were searched from inception to 4 November 2024. Observational studies reporting depressive or anxiety symptoms and CVH defined by Life’s Simple 7, Life’s Essential 8, or adapted composite indices were eligible. Study quality was appraised using the Newcastle-Ottawa Scale and a narrative synthesis was conducted. Findings: Of 25 full-text articles assessed, 11 studies ( n = 731,650; mean age 22–48 years) met the inclusion criteria. Nine were conducted in the United States, one in China, and one in Puerto Rico. Seven cross-sectional studies reported an inverse association between CVH and CMDs, with higher CVH associated with lower odds or prevalence of depressive and anxiety symptoms. Four studies, including one cohort, found that CMDs were associated with lower CVH, reflected by higher odds of suboptimal CVH, lower prevalence of ideal CVH, and reduced CVH scores. Conclusions: Findings suggest a potential bidirectional relationship between CVH and CMDs among adults, though this is inferred from separate analyses rather than directly established using the same studies. Integrated strategies promoting physical activity, a healthy diet, and stress management, alongside primary care initiatives incorporating behavioural support and screening for cardiovascular and mental health risks, may benefit both conditions. Interpretation is limited by the predominance of cross-sectional studies and heterogeneity in study designs, with most studies conducted in high-income settings. Future research should prioritise longitudinal designs and apply diverse analytical methods to better clarify directionality. Registration: PROSPERO (CRD42024621494).
- Open Access
- 11 May 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (5) , 631
Correction: Hongoro et al. Economic Burden of Human Immunodeficiency Virus and Hypertension Care Among MOPHADHIV Trial Participants: Patient Costs and Determinants of Out-of-Pocket Expenditure in South Africa. Int. J. Environ. Res. Public Health 2025, 22, 1488
- 11 May 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (5) , 631
Open AccessCorrection: Hongoro et al. Economic Burden of Human Immunodeficiency Virus and Hypertension Care Among MOPHADHIV Trial Participants: Patient Costs and Determinants of Out-of-Pocket Expenditure in South Africa. Int. J. Environ. Res. Public Health 2025, 22, 1488
- Open Access
- 25 September 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (10) , 1488
Economic Burden of Human Immunodeficiency Virus and Hypertension Care Among MOPHADHIV Trial Participants: Patient Costs and Determinants of Out-of-Pocket Expenditure in South Africa
Background: Human immunodeficiency virus and hypertension increasingly co-occur in South Africa. Despite publicly funded care, patients with multimorbidity face high out-of-pocket costs, yet limited evidence exists from the patient perspective. Purpose: To quantify the economic burden of comorbid HIV and hypertension, assess predictors of monthly out-of-pocket costs, and explore coping mechanisms. Methods: We conducted a cross-sectional analysis using patient-level data from the Mobile Phone Text Messages to Improve Hypertension Medication Adherence in Adults with HIV (MOPHADHIV trial) [Trial number: PACTR201811878799717], a randomized controlled trial evaluating short messages services adherence support for hypertension care in people with HIV. We calculated the monthly direct non-medical, indirect, and coping costs from a patient perspective, valuing indirect costs using both actual income and minimum wage assumptions. Generalized linear models with a gamma distribution and log link were used to identify cost determinants. Catastrophic expenditure thresholds (10–40% of monthly income) were assessed. Results: Among 683 participants, mean monthly total costs were ZAR 105.81 (USD 5.72) using actual income and ZAR 182.3 (USD 9.9) when valuing indirect costs by minimum wage. These time-related productivity losses constituted the largest share of overall expenses. Regression models revealed a strong income gradient: participants in the richest quintile incurred ZAR 131.9 (95% CI: 63.6–200.1) more per month than the poorest. However, this gradient diminished or reversed under standardized wage assumptions, suggesting a heavier proportional burden on middle-income groups. Other socio-demographic factors (gender, employment, education) not significantly associated with total costs, likely reflecting the broad reach of South Africa’s primary health system. Nearly half of the participants also reported resorting to coping mechanisms such as borrowing or asset sales. Conclusions: Comorbid HIV and hypertension impose substantial patient costs, predominantly indirect. Income disparities drive variation, raising equity concerns. Strengthening integrated human immunodeficiency virus—non-communicable diseases care and targeting financial support are key to advancing South Africa’s Universal Health Coverage reforms.
- 25 September 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (10) , 1488
Open AccessEconomic Burden of Human Immunodeficiency Virus and Hypertension Care Among MOPHADHIV Trial Participants: Patient Costs and Determinants of Out-of-Pocket Expenditure in South Africa
Background: Human immunodeficiency virus and hypertension increasingly co-occur in South Africa. Despite publicly funded care, patients with multimorbidity face high out-of-pocket costs, yet limited evidence exists from the patient perspective. Purpose: To quantify the economic burden of comorbid HIV and hypertension, assess predictors of monthly out-of-pocket costs, and explore coping mechanisms. Methods: We conducted a cross-sectional analysis using patient-level data from the Mobile Phone Text Messages to Improve Hypertension Medication Adherence in Adults with HIV (MOPHADHIV trial) [Trial number: PACTR201811878799717], a randomized controlled trial evaluating short messages services adherence support for hypertension care in people with HIV. We calculated the monthly direct non-medical, indirect, and coping costs from a patient perspective, valuing indirect costs using both actual income and minimum wage assumptions. Generalized linear models with a gamma distribution and log link were used to identify cost determinants. Catastrophic expenditure thresholds (10–40% of monthly income) were assessed. Results: Among 683 participants, mean monthly total costs were ZAR 105.81 (USD 5.72) using actual income and ZAR 182.3 (USD 9.9) when valuing indirect costs by minimum wage. These time-related productivity losses constituted the largest share of overall expenses. Regression models revealed a strong income gradient: participants in the richest quintile incurred ZAR 131.9 (95% CI: 63.6–200.1) more per month than the poorest. However, this gradient diminished or reversed under standardized wage assumptions, suggesting a heavier proportional burden on middle-income groups. Other socio-demographic factors (gender, employment, education) not significantly associated with total costs, likely reflecting the broad reach of South Africa’s primary health system. Nearly half of the participants also reported resorting to coping mechanisms such as borrowing or asset sales. Conclusions: Comorbid HIV and hypertension impose substantial patient costs, predominantly indirect. Income disparities drive variation, raising equity concerns. Strengthening integrated human immunodeficiency virus—non-communicable diseases care and targeting financial support are key to advancing South Africa’s Universal Health Coverage reforms.
- Open Access
- 8 August 2025
- Published by MDPI AG in Preprints.org
Economic Burden of HIV and Hypertension Care Among MOPHADHIV Trial Participants: Patient Costs and Determinants of Out-of-Pocket Expenditure in South Africa
Background: The rising co-occurrence of HIV and hypertension in sub-Saharan Africa (SSA) presents complex challenges for patients and health systems. In South Africa, despite free healthcare services for HIV and hypertension in the public sector, patients with multiple chronic conditions frequently incur substantial out-of-pocket (OOP) costs. However, limited empirical evidence quantifies this burden from the patient perspective. Purpose: To quantify the economic burden of managing comorbid HIV and hypertension among South African patients, identify socio-demographic predictors of monthly OOP expenditure, and assess financial coping mechanisms. Methods: We conducted a cross-sectional analysis using patient-level data from the MOPHADHIV trial [Trial number: PACTR201811878799717], a randomized controlled trial evaluating SMS adherence support for hypertension care in people with HIV. We calculated the monthly direct non-medical, indirect, and coping costs from a patient perspective, valuing indirect costs using both actual income and minimum wage assumptions. Generalized linear models (GLMs) with a gamma distribution and log link were used to identify cost determinants. Catastrophic expenditure thresholds (10–40% of monthly income) were assessed. Results: Among 683 participants, mean monthly total costs were ZAR 105.81 (USD 5.72) when valuing indirect costs by actual income and ZAR 182.3 (USD 9.9) using minimum wage assumptions. Indirect costs were the largest cost component. Regression models revealed a significant income gradient: participants in the richest quintile incurred ZAR 131.9 (95% CI: 63.6–200.1) more costs per month than the poorest participants (p < 0.00). However, when indirect costs were standardized by minimum wage, cost gradients attenuated or reversed, indicating greater relative burden among middle-income groups. Other socio-demographic factors (gender, employment, education) were not significantly associated with total costs, which may reflect the relative success of South Africa’s district health system and its emphasis on equitable access to primary care that is free at the point of service. Nearly half the participants reported coping costs. Conclusion: Managing comorbid HIV and hypertension imposes substantial economic burdens on patients, primarily driven by indirect costs. Income-related disparities dominate cost variation, with important implications for financial protection and equity. Strengthening the integration of HIV and NCD services and targeting financial support for lower-income patients are critical to advancing South Africa’s Universal Health Coverage reforms.
- 8 August 2025
- Published by MDPI AG in Preprints.org
Open AccessEconomic Burden of HIV and Hypertension Care Among MOPHADHIV Trial Participants: Patient Costs and Determinants of Out-of-Pocket Expenditure in South Africa
Background: The rising co-occurrence of HIV and hypertension in sub-Saharan Africa (SSA) presents complex challenges for patients and health systems. In South Africa, despite free healthcare services for HIV and hypertension in the public sector, patients with multiple chronic conditions frequently incur substantial out-of-pocket (OOP) costs. However, limited empirical evidence quantifies this burden from the patient perspective. Purpose: To quantify the economic burden of managing comorbid HIV and hypertension among South African patients, identify socio-demographic predictors of monthly OOP expenditure, and assess financial coping mechanisms. Methods: We conducted a cross-sectional analysis using patient-level data from the MOPHADHIV trial [Trial number: PACTR201811878799717], a randomized controlled trial evaluating SMS adherence support for hypertension care in people with HIV. We calculated the monthly direct non-medical, indirect, and coping costs from a patient perspective, valuing indirect costs using both actual income and minimum wage assumptions. Generalized linear models (GLMs) with a gamma distribution and log link were used to identify cost determinants. Catastrophic expenditure thresholds (10–40% of monthly income) were assessed. Results: Among 683 participants, mean monthly total costs were ZAR 105.81 (USD 5.72) when valuing indirect costs by actual income and ZAR 182.3 (USD 9.9) using minimum wage assumptions. Indirect costs were the largest cost component. Regression models revealed a significant income gradient: participants in the richest quintile incurred ZAR 131.9 (95% CI: 63.6–200.1) more costs per month than the poorest participants (p < 0.00). However, when indirect costs were standardized by minimum wage, cost gradients attenuated or reversed, indicating greater relative burden among middle-income groups. Other socio-demographic factors (gender, employment, education) were not significantly associated with total costs, which may reflect the relative success of South Africa’s district health system and its emphasis on equitable access to primary care that is free at the point of service. Nearly half the participants reported coping costs. Conclusion: Managing comorbid HIV and hypertension imposes substantial economic burdens on patients, primarily driven by indirect costs. Income-related disparities dominate cost variation, with important implications for financial protection and equity. Strengthening the integration of HIV and NCD services and targeting financial support for lower-income patients are critical to advancing South Africa’s Universal Health Coverage reforms.
- Open Access
- 24 May 2025
- Published by Elsevier in Obesity Pillars
- Vol. 15, 100182
Comorbidities of childhood obesity at a tertiary hospital in Kwazulu-Natal, South Africa
- 24 May 2025
- Published by Elsevier in Obesity Pillars
- Vol. 15, 100182
Open AccessComorbidities of childhood obesity at a tertiary hospital in Kwazulu-Natal, South Africa
- Open Access
- 6 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-9
Prevalence and associations of hypertension detection, treatment and control in Cape Town
Globally, the prevalence of hypertension is high and rising; however, hypertension care remains suboptimal, including in South Africa. Therefore, the aim of this study was to determine the prevalence and associations of hypertension detection, treatment and control in > 21-year-old urban black residents with hypertension in Cape Town, South Africa. In this randomly selected community-based cross-sectional study, data collection comprised administered questionnaires, clinical measurements and fasting biochemical analyses, including oral glucose tolerance tests. Hypertension was defined as blood pressure ≥ 140/90 mmHg or known hypertension on treatment. Separate logistic regression models evaluated the associations with hypertension detection, treatment and control. Each model included sociodemographic characteristics, problem drinking, daily tobacco smoking, family history of hypertension, obesity (body mass index ≥ 30 kg/m2), and comorbidities of diabetes, high low-density lipoprotein cholesterol and chronic kidney disease (CKD). Among 460 participants with hypertension, 65% were women and the mean age was 50.7 (SD ± 12.1) years. Prevalence of hypertension detection among participants with hypertension (62.4%), treatment among the detected (75.6%) and control among the treated (57.1%) were sub-optimal, with better rates in women (73.6%, 80.0%, 59.1%, respectively) than in men (41.6%, 61.2%, 48.8%) (p < 0.05 for detection and treatment). Hypertension detection among participants with hypertension was associated with age ≥ 45 years, female gender (OR: 3.56, 95%CI: 1.94–6.55), a family history of hypertension (OR: 1.81, 95% CI: 1.09–3.00), ≤ 7 years of education (OR: 1.76, 95%CI: 1.02–3.03), ≥ 50% of life spent in city (OR: 1.82, 95%CI: 1.07–3.10) and comorbid diabetes (OR: 3.51, 95%CI: 1.80–6.86) or CKD (OR: 6.27, 95%CI: 1.31–30.10). The poorest participants were half as likely as their counterparts to have their hypertension detected (OR: 0.51, 95%CI: 0.28–0.92). Treated hypertension in those detected was significantly associated with female gender (OR: 3.29, 95% CI: 1.42–7.67) and just missed being associated with comorbid diabetes (OR: 2.00, 95% CI: 0.99–4.03). Hypertension control among participants who were treated was significantly associated with female gender (OR: 2.36, 95%CI: 1.01–5.51) in the logistic regression analyses. Participants who were female and with comorbid diabetes were more likely to have better hypertension care overall, while the poorest and less urbanised participants were less likely to have their hypertension detected. Strategies are required to ensure equitable distribution of hypertension care. In-depth research is required to understand the contributors to suboptimal hypertension care, which likely differ by age, gender, socioeconomic status and level of care.
- 6 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-9
Open AccessPrevalence and associations of hypertension detection, treatment and control in Cape Town
Globally, the prevalence of hypertension is high and rising; however, hypertension care remains suboptimal, including in South Africa. Therefore, the aim of this study was to determine the prevalence and associations of hypertension detection, treatment and control in > 21-year-old urban black residents with hypertension in Cape Town, South Africa. In this randomly selected community-based cross-sectional study, data collection comprised administered questionnaires, clinical measurements and fasting biochemical analyses, including oral glucose tolerance tests. Hypertension was defined as blood pressure ≥ 140/90 mmHg or known hypertension on treatment. Separate logistic regression models evaluated the associations with hypertension detection, treatment and control. Each model included sociodemographic characteristics, problem drinking, daily tobacco smoking, family history of hypertension, obesity (body mass index ≥ 30 kg/m2), and comorbidities of diabetes, high low-density lipoprotein cholesterol and chronic kidney disease (CKD). Among 460 participants with hypertension, 65% were women and the mean age was 50.7 (SD ± 12.1) years. Prevalence of hypertension detection among participants with hypertension (62.4%), treatment among the detected (75.6%) and control among the treated (57.1%) were sub-optimal, with better rates in women (73.6%, 80.0%, 59.1%, respectively) than in men (41.6%, 61.2%, 48.8%) (p < 0.05 for detection and treatment). Hypertension detection among participants with hypertension was associated with age ≥ 45 years, female gender (OR: 3.56, 95%CI: 1.94–6.55), a family history of hypertension (OR: 1.81, 95% CI: 1.09–3.00), ≤ 7 years of education (OR: 1.76, 95%CI: 1.02–3.03), ≥ 50% of life spent in city (OR: 1.82, 95%CI: 1.07–3.10) and comorbid diabetes (OR: 3.51, 95%CI: 1.80–6.86) or CKD (OR: 6.27, 95%CI: 1.31–30.10). The poorest participants were half as likely as their counterparts to have their hypertension detected (OR: 0.51, 95%CI: 0.28–0.92). Treated hypertension in those detected was significantly associated with female gender (OR: 3.29, 95% CI: 1.42–7.67) and just missed being associated with comorbid diabetes (OR: 2.00, 95% CI: 0.99–4.03). Hypertension control among participants who were treated was significantly associated with female gender (OR: 2.36, 95%CI: 1.01–5.51) in the logistic regression analyses. Participants who were female and with comorbid diabetes were more likely to have better hypertension care overall, while the poorest and less urbanised participants were less likely to have their hypertension detected. Strategies are required to ensure equitable distribution of hypertension care. In-depth research is required to understand the contributors to suboptimal hypertension care, which likely differ by age, gender, socioeconomic status and level of care.
- Open Access
- 5 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0318156
Non-communicable disease and mental health care during the COVID-19 pandemic in South Africa: Perspectives from selected healthcare professionals and patients
Aim: South Africa has a high burden of non-communicable diseases (NCDs) and experienced a high COVID-19 caseload, while the healthcare system was already overstretched. The aim of this study was to examine the perceptions and experiences of 1) healthcare professionals (HPs) of COVID-19 and NCD management, and the preparedness of health systems to provide NCD care, and 2) people living with NCDs (PLWNCDs) on the care they received, their mental health status and the availability of health information during the COVID-19 pandemic in South Africa. Methods: We recruited a convenience sample of 1) HPs who worked in healthcare management, i.e., public health officials and healthcare workers who provided care and engaged with patients in any healthcare capacity, and 2) PLWNCDs with ≥1 NCD. Questionnaires comprised quantitative and some open-ended follow-up questions. SPSS was used to analyse the quantitative data, and content analysis with inductive reasoning was used to evaluate the open-ended questions. Results: This cross-sectional study comprised 31 HPs and 79 PLWNCDs. The provision of COVID-19 care was perceived to be adequate by HPs while NCD care was poor with disruptions of services, including for emergency and specialised NCDs care. Strategies to care for non-COVID-19 illnesses during the pandemic were lacking. This would have serious long-term consequences for PLWNCDs and the healthcare system. Perceptions of inadequate NCD care were repeated by PLWNCDs; 49% felt they received ‘very little’ or no adequate care and 18% had a scheduled appointment cancelled. Further, many PLWNCDs (52%) felt anxious, lonely or frightened during the pandemic and 15% felt their mental health had deteriorated, but only a small proportion sought medical attention. The utility of digital health was positively perceived by both HPs and PLWNCDs and could contribute to better health provision during crises. Conclusions: Policies are needed to ensure that NCD care will not be neglected during future crises and to encourage PLWNCDs to access healthcare services timeously during such periods. Potential strategies may utilise digital health apps to improve care and to address the mental healthcare needs of PLWNCDs.
- 5 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0318156
Open AccessNon-communicable disease and mental health care during the COVID-19 pandemic in South Africa: Perspectives from selected healthcare professionals and patients
Aim: South Africa has a high burden of non-communicable diseases (NCDs) and experienced a high COVID-19 caseload, while the healthcare system was already overstretched. The aim of this study was to examine the perceptions and experiences of 1) healthcare professionals (HPs) of COVID-19 and NCD management, and the preparedness of health systems to provide NCD care, and 2) people living with NCDs (PLWNCDs) on the care they received, their mental health status and the availability of health information during the COVID-19 pandemic in South Africa. Methods: We recruited a convenience sample of 1) HPs who worked in healthcare management, i.e., public health officials and healthcare workers who provided care and engaged with patients in any healthcare capacity, and 2) PLWNCDs with ≥1 NCD. Questionnaires comprised quantitative and some open-ended follow-up questions. SPSS was used to analyse the quantitative data, and content analysis with inductive reasoning was used to evaluate the open-ended questions. Results: This cross-sectional study comprised 31 HPs and 79 PLWNCDs. The provision of COVID-19 care was perceived to be adequate by HPs while NCD care was poor with disruptions of services, including for emergency and specialised NCDs care. Strategies to care for non-COVID-19 illnesses during the pandemic were lacking. This would have serious long-term consequences for PLWNCDs and the healthcare system. Perceptions of inadequate NCD care were repeated by PLWNCDs; 49% felt they received ‘very little’ or no adequate care and 18% had a scheduled appointment cancelled. Further, many PLWNCDs (52%) felt anxious, lonely or frightened during the pandemic and 15% felt their mental health had deteriorated, but only a small proportion sought medical attention. The utility of digital health was positively perceived by both HPs and PLWNCDs and could contribute to better health provision during crises. Conclusions: Policies are needed to ensure that NCD care will not be neglected during future crises and to encourage PLWNCDs to access healthcare services timeously during such periods. Potential strategies may utilise digital health apps to improve care and to address the mental healthcare needs of PLWNCDs.
- Open Access
- 28 October 2024
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 34 (Supplement)
Poor psychosocial status and cardiovascular risk factors are associated with depression or anxiety
Background: Depression and anxiety are rising in South Africa but their associations with psychosocial and cardiovascular risk factors (CVRFs) remain under explored. This study determined the associations of depression and anxiety traits with poor psychosocial wellbeing, risky lifestyle behaviours and cardiometabolic diseases. Methods: In a population-based cross-sectional study, data were collected via administered questionnaires, clinical examinations and biochemical assessments. Depression and anxiety traits were ascertained via the Patient Health Questionnaire-9 and Generalised Anxiety Disorder screening questions. Multivariable logistic regressions determined the associations with depression and anxiety traits; the basic model comprised sociodemographic factors, physical inactivity, tobacco smoking and alcohol misuse (CAGE ≥2). Psychosocial and cardiometabolic variables were entered individually in separate models. Results: Among 678 participants, median age 52 years and mainly women (81%), prevalence of depression scores ≥10 were 14.2% (men:12.7%, women:14.6%, p = 0.498) and anxiety scores ≥10 were 10.2% (men:10.3%, women:10.2%). In the basic regression models, depression, but not anxiety, was associated with being separated, living as married/widowed vs. single (OR:2.01, 95%CI:1.02-3.94), and alcohol misuse (2.07, 1.13-3.78). Depression and anxiety were associated with decreasing social support (depression: 1.09, 1.04-1.12; anxiety: 1.09, 1.04-1.14), and increasing number of adverse life events. Hypertension (1.76, 1.07-2.90, p = 0.025), diabetes (1.98, 1.03-3.82, p = 0.041) and dyslipidaemia (1.97, 1.01-3.85, p = 0.048) were associated with depression but not anxiety. Conclusions: The high burden and associations of depression and anxiety traits with poor psychosocial wellbeing suggest a need for holistic care approaches. The associations of depression traits with CVRFs warrant screening and care of depression in the presence of cardiometabolic diseases and alcohol misuse. Key messages: • The high burden of depression and anxiety traits in South Africa is associated with poor social support and quality of life, and increasing adverse life events experienced. • The associations of depression traits with hypertension, diabetes, dyslipidaemia, and alcohol misuse highlight the need for integrated management strategies.
- 28 October 2024
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 34 (Supplement)
Open AccessPoor psychosocial status and cardiovascular risk factors are associated with depression or anxiety
Background: Depression and anxiety are rising in South Africa but their associations with psychosocial and cardiovascular risk factors (CVRFs) remain under explored. This study determined the associations of depression and anxiety traits with poor psychosocial wellbeing, risky lifestyle behaviours and cardiometabolic diseases. Methods: In a population-based cross-sectional study, data were collected via administered questionnaires, clinical examinations and biochemical assessments. Depression and anxiety traits were ascertained via the Patient Health Questionnaire-9 and Generalised Anxiety Disorder screening questions. Multivariable logistic regressions determined the associations with depression and anxiety traits; the basic model comprised sociodemographic factors, physical inactivity, tobacco smoking and alcohol misuse (CAGE ≥2). Psychosocial and cardiometabolic variables were entered individually in separate models. Results: Among 678 participants, median age 52 years and mainly women (81%), prevalence of depression scores ≥10 were 14.2% (men:12.7%, women:14.6%, p = 0.498) and anxiety scores ≥10 were 10.2% (men:10.3%, women:10.2%). In the basic regression models, depression, but not anxiety, was associated with being separated, living as married/widowed vs. single (OR:2.01, 95%CI:1.02-3.94), and alcohol misuse (2.07, 1.13-3.78). Depression and anxiety were associated with decreasing social support (depression: 1.09, 1.04-1.12; anxiety: 1.09, 1.04-1.14), and increasing number of adverse life events. Hypertension (1.76, 1.07-2.90, p = 0.025), diabetes (1.98, 1.03-3.82, p = 0.041) and dyslipidaemia (1.97, 1.01-3.85, p = 0.048) were associated with depression but not anxiety. Conclusions: The high burden and associations of depression and anxiety traits with poor psychosocial wellbeing suggest a need for holistic care approaches. The associations of depression traits with CVRFs warrant screening and care of depression in the presence of cardiometabolic diseases and alcohol misuse. Key messages: • The high burden of depression and anxiety traits in South Africa is associated with poor social support and quality of life, and increasing adverse life events experienced. • The associations of depression traits with hypertension, diabetes, dyslipidaemia, and alcohol misuse highlight the need for integrated management strategies.
- Open Access
- 28 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Exploring the associations of tobacco smoking and serum cotinine levels with selected inflammatory markers in adults with HIV in South Africa
This study examined the associations between tobacco smoking and serum cotinine levels, an objective biochemical measure of tobacco smoke exposure, with markers of inflammation, i.e., interferon-gamma (IFN-γ), interleukin 10 (IL-10), interleukin 2 (IL-2) and tumour necrosis factor-alpha (TNF-α) in people living with HIV (PLWH).These specific markers were selected because of their hypothesised associations with smoking, PLWH and their outcomes. In a random sample of ≥ 18-year-old PLWH receiving care at 17 public healthcare facilities across the Western Cape Province in South Africa, data collection included self-reported smoking history, and serum levels of cotinine and selected inflammatory markers. The inflammatory marker data were log transformed because of the skewedness of their distribution. Linear regression models (1) adjusted for age and gender, and (2) fully adjusted for age, gender, current alcohol use, body mass index and CD4 counts were used to examine the associations between smoking tobacco or serum cotinine and inflammatory markers. Level of significance was p < 0.05. Among 749 PLWH who were mainly women (79%), the mean age was 38.5 (8.9) years and similar when stratified by smoking status. Serum cotinine levels exhibited a striking discrepancy, with a median of 154 ng/mL among current smokers, in stark contrast to the consistent median values of 10 ng/mL observed among past and never smokers. In regression models adjusted for age and gender, current smoking and frequent smoking were associated with lower IL-2 but higher TNF-α. Log-cotinine exhibited associations with IFN-γ, IL-10, and TNF-α, while cotinine levels ≥ 10 ng/mL compared to < 10 ng/mL were associated with higher IFN-γ and TNF-α. In fully adjusted models, log-cotinine and cotinine levels ≥ 10 ng/mL displayed significant associations with higher IFN-γ and lower IL-2. This study underscores the importance of investigating the interplay between smoking tobacco or serum cotinine levels with pro-inflammatory cytokines in PLWH. It signals the need for comprehensive research to unravel the potential synergistic impacts of smoking tobacco and HIV infection on chronic inflammation and immune dysregulation, shedding light on critical avenues for intervention and management strategies.
- 28 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Open AccessExploring the associations of tobacco smoking and serum cotinine levels with selected inflammatory markers in adults with HIV in South Africa
This study examined the associations between tobacco smoking and serum cotinine levels, an objective biochemical measure of tobacco smoke exposure, with markers of inflammation, i.e., interferon-gamma (IFN-γ), interleukin 10 (IL-10), interleukin 2 (IL-2) and tumour necrosis factor-alpha (TNF-α) in people living with HIV (PLWH).These specific markers were selected because of their hypothesised associations with smoking, PLWH and their outcomes. In a random sample of ≥ 18-year-old PLWH receiving care at 17 public healthcare facilities across the Western Cape Province in South Africa, data collection included self-reported smoking history, and serum levels of cotinine and selected inflammatory markers. The inflammatory marker data were log transformed because of the skewedness of their distribution. Linear regression models (1) adjusted for age and gender, and (2) fully adjusted for age, gender, current alcohol use, body mass index and CD4 counts were used to examine the associations between smoking tobacco or serum cotinine and inflammatory markers. Level of significance was p < 0.05. Among 749 PLWH who were mainly women (79%), the mean age was 38.5 (8.9) years and similar when stratified by smoking status. Serum cotinine levels exhibited a striking discrepancy, with a median of 154 ng/mL among current smokers, in stark contrast to the consistent median values of 10 ng/mL observed among past and never smokers. In regression models adjusted for age and gender, current smoking and frequent smoking were associated with lower IL-2 but higher TNF-α. Log-cotinine exhibited associations with IFN-γ, IL-10, and TNF-α, while cotinine levels ≥ 10 ng/mL compared to < 10 ng/mL were associated with higher IFN-γ and TNF-α. In fully adjusted models, log-cotinine and cotinine levels ≥ 10 ng/mL displayed significant associations with higher IFN-γ and lower IL-2. This study underscores the importance of investigating the interplay between smoking tobacco or serum cotinine levels with pro-inflammatory cytokines in PLWH. It signals the need for comprehensive research to unravel the potential synergistic impacts of smoking tobacco and HIV infection on chronic inflammation and immune dysregulation, shedding light on critical avenues for intervention and management strategies.
- Open Access
- 30 July 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (7) , e0003434
Interdisciplinary perspectives on multimorbidity in Africa: Developing an expanded conceptual model
Multimorbidity is an emerging challenge for health systems globally. It is commonly defined as the co-occurrence of two or more chronic conditions in one person, but its meaning remains a lively area of academic debate, and the utility of the concept beyond high-income settings is uncertain. This article presents the findings from an interdisciplinary research initiative that drew together 60 academic and applied partners working in 10 African countries to answer the questions: how useful is the concept of multimorbidity within Africa? Can the concept be adapted to context to optimise its transformative potentials? During a three-day concept-building workshop, we investigated how the definition of multimorbidity was understood across diverse disciplinary and regional perspectives, evaluated the utility and limitations of existing concepts and definitions, and considered how to build a more context-sensitive, cross-cutting description of multimorbidity. This iterative process was guided by the principles of grounded theory and involved focus- and whole-group discussions during the workshop, thematic coding of workshop discussions, and further post-workshop development and refinement. Three thematic domains emerged from workshop discussions: the current focus of multimorbidity on constituent diseases; the potential for revised concepts to centre the priorities, needs, and social context of people living with multimorbidity (PLWMM); and the need for revised concepts to respond to varied conceptual priorities amongst stakeholders. These themes fed into the development of an expanded conceptual model that centres the catastrophic impacts multimorbidity can have for PLWMM, families and support structures, service providers, and health systems.
- 30 July 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (7) , e0003434
Open AccessInterdisciplinary perspectives on multimorbidity in Africa: Developing an expanded conceptual model
Multimorbidity is an emerging challenge for health systems globally. It is commonly defined as the co-occurrence of two or more chronic conditions in one person, but its meaning remains a lively area of academic debate, and the utility of the concept beyond high-income settings is uncertain. This article presents the findings from an interdisciplinary research initiative that drew together 60 academic and applied partners working in 10 African countries to answer the questions: how useful is the concept of multimorbidity within Africa? Can the concept be adapted to context to optimise its transformative potentials? During a three-day concept-building workshop, we investigated how the definition of multimorbidity was understood across diverse disciplinary and regional perspectives, evaluated the utility and limitations of existing concepts and definitions, and considered how to build a more context-sensitive, cross-cutting description of multimorbidity. This iterative process was guided by the principles of grounded theory and involved focus- and whole-group discussions during the workshop, thematic coding of workshop discussions, and further post-workshop development and refinement. Three thematic domains emerged from workshop discussions: the current focus of multimorbidity on constituent diseases; the potential for revised concepts to centre the priorities, needs, and social context of people living with multimorbidity (PLWMM); and the need for revised concepts to respond to varied conceptual priorities amongst stakeholders. These themes fed into the development of an expanded conceptual model that centres the catastrophic impacts multimorbidity can have for PLWMM, families and support structures, service providers, and health systems.